In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

Need help?

Read the Frequently Asked Questions for a better use

Read more

 

Refine your search
Sponsors

ESC Congress 365

All ESC Congress resources in one online library

View thousands of videos, slides, abstracts and reports from the world's largest cardiovascular congress – anytime!

Any question or suggestion? Check the Frequently Asked Questions or send it to us by email.

 

 

ESC Congress 365 only features abstracts, slides, reports and/or videos for which the speakers and/or presenters have granted the European Society of Cardiology the rights to use for educational purposes.

presentations found in .

Poster session 3 : Anticoagulation in atrial fibrillation II
Abstract Slides/e-posters Video Report ESC TV Interview
 
Is Aspirin monotherapy effective for stroke prevention in the real world? A UK cohort study evaluating the incidence of stroke in the absence of anticoagulation in atrial fibrillation (AF)
Presenter: E Ridha (London,GB)
2016
more
 
Poor anticoagulation control in warfarin treated atrial fibrillation patients with reduced renal function
Presenter: A Nissen Bonde (Hellerup,DK)
2016
more
 
In-hospital mortality, length of stay and costs of treating atrial fibrillation or flutter patients admitted for intracranial hemorrhage
Presenter: E Nguyen (West Hartford,US)
2016
more
 
One-year permeability rate of left atrial appendage closure devices: high incidence of peridevice leak and lack of endothelialization
Presenter: G Laugaudin (Marvejols,FR)
2016
more
 
Net clinical benefit of rivaroxaban compared with warfarin in patients with atrial fibrillation
Presenter: J Piccini (Durham,US)
2016
more
 
Major bleeding risk in patients 75 years of age or older with non-valvular atrial fibrillation initiating oral anticoagulants: a real-world comparison of warfarin, apixaban, dabigatran, or rivaroxaban
Presenter: G Y H Lip (Birmingham,GB)
2016
more
 
Non-vitamin K antagonist oral anticoagulation usage in elderly patients with atrial fibrillation: Danish nationwide data with temporal trends from 2011 to 2015
Presenter: L Staerk (Hellerup,DK)
2016
more
 
Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)
Presenter: G Y H Lip (Birmingham,GB)
2016
more
 
Real - world evidence of stroke prevention in patients with non-valvular atrial fibrillation
Presenter: C Coleman (Windsor,US)
2016
more
 
Patients' convenience and satisfaction as important factors related to switching from vitamin K antagonists to NOACs - a PREFER in AF Registry analysis
Presenter: R De Caterina (Chieti,IT)
2016
more

The scientific programme has been prepared by the Congress Programme Committee in close collaboration with the ESC Working Groups, ESC Associations and the ESC Councils.

 

Related Session